Abstract
Oral squamous cell carcinoma (OSCC) is one of the leading cancers in the world. OSCC patients are managed with surgery and/or chemoradiation. Prognoses and survival rates are dismal, however, and have not improved for more than 20 years. Recently, the concept of precision medicine was introduced, and the introduction of targeted therapeutics demonstrated promising outcomes. This article reviews the current understanding of initiation, progression, and metastasis of OSCC from both genetic and epigenetic perspectives. In addition, the applications and integration of omics technologies in biomarker discovery and drug development for treating OSCC are reviewed.
Original language | English (US) |
---|---|
Pages (from-to) | 127-144 |
Number of pages | 18 |
Journal | Surgical Oncology Clinics of North America |
Volume | 29 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2020 |
Keywords
- Big data
- Epigenetics
- Malignant transformation
- Omics technology
- Oral cancer
- Oral squamous cell carcinoma
- Personalized medicine
- Precision medicine
ASJC Scopus subject areas
- Surgery
- Oncology